Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study ; volume:21 ; number:1 ; day:21 ; month:10 ; year:2017 ; pages:1-14 ; date:12.2017
Critical care ; 21, Heft 1 (21.10.2017), 1-14, 12.2017
- Schlagwort
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Urheber
- Beteiligte Personen und Organisationen
-
Zoller, Michael
Minichmayr, Iris K.
Scharf, Christina
Maier, Barbara
Schmitt, Maximilian V.
Hartung, Niklas
Huisinga, Wilhelm
Vogeser, Michael
Frey, Lorenz
Zander, Johannes
Kloft, Charlotte
SpringerLink (Online service)
- DOI
-
10.1186/s13054-017-1829-4
- URN
-
urn:nbn:de:1111-201712165954
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ehmann, Lisa
- Zoller, Michael
- Minichmayr, Iris K.
- Scharf, Christina
- Maier, Barbara
- Schmitt, Maximilian V.
- Hartung, Niklas
- Huisinga, Wilhelm
- Vogeser, Michael
- Frey, Lorenz
- Zander, Johannes
- Kloft, Charlotte
- SpringerLink (Online service)
Ähnliche Objekte (12)
Population pharmacokinetics of meropenem in critically ill patients
A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies
Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target Attainment
Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis
Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis
Impact of Continuous Infusion Meropenem PK/PD Target Attainment on C-Reactive Protein Dynamics in Critically Ill Patients With Documented Gram-Negative Hospital-Acquired or Ventilator-Associated Pneumonia
Population pharmacokinetics of meropenem in critically ill patients
A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies
Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target Attainment
Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis
Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis
Impact of Continuous Infusion Meropenem PK/PD Target Attainment on C-Reactive Protein Dynamics in Critically Ill Patients With Documented Gram-Negative Hospital-Acquired or Ventilator-Associated Pneumonia
Population pharmacokinetics of meropenem in critically ill patients
A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies
Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target Attainment
Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis
Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis